Research Archive — Page 114 of 139

November 29, 2018

Parsing diabetic skin infections

Vanderbilt researchers have discovered a role for an inflammatory mediator in diabetic skin infections, suggesting new therapeutic targets for this common complication of diabetes.

Head-and-shoulders portrait of a smiling woman with short auburn hair and glasses, wearing a black jacket.
November 15, 2018

Lynn Maquat, PhD, to give Vanderbilt Prize lecture Nov. 29

Lynne Maquat, PhD, recipient of the 2017 Vanderbilt Prize in Biomedical Science whose work has advanced our understanding of human gene expression, will deliver her Vanderbilt Prize lecture as part of the Flexner Discovery Lecture series on Nov. 29.

Five male medical professionals stand outdoors in white laboratory coats, with leafy trees and a building behind them.
November 15, 2018

Immunotherapies linked to specific heart complications

In the first large-scale analysis of cardiovascular complications linked to immune checkpoint inhibitors, Vanderbilt researchers have shown that heart and vessel complications include myocarditis, pericarditis, vasculitis and arrhythmias, and that they occur early in the course of treatment.

Lymphocytes attacking cancer cell
November 8, 2018

Evading cell death

Stress granules that form in response to cellular stress help cancer cells survive and develop resistance to treatment.

Stack of vitamin C tablets beside whole and halved oranges with green leaves on a white background.
November 8, 2018

Vitamin C protects brain from seizures

Brain ascorbate — vitamin C — is important for protecting the brain against seizures and cognitive decline in Alzheimer’s disease.

Close-up of a brown eye overlaid with blurred ophthalmic eye-chart letters and numbers.
November 8, 2018

Novel methods to treat glaucoma

Increasing a certain signaling molecule prevents the degeneration of retinal cells that are lost in glaucoma, suggesting a new way to treat this disease.